TinCat LGBTQ+ Smoking Cessation Via Asynchronous Telehealth
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05499364 |
Recruitment Status :
Not yet recruiting
First Posted : August 12, 2022
Last Update Posted : August 16, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Tobacco Use Disorder Tobacco Use Cessation | Behavioral: TinCat Behavioral: Quit.gov program | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 30 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Participants will be assigned to the control or intervention groups randomly. |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | TinCat Tobacco Cessation Protocol for LGBTQ+ Austinites |
Estimated Study Start Date : | January 1, 2023 |
Estimated Primary Completion Date : | April 30, 2023 |
Estimated Study Completion Date : | June 30, 2023 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Quit.gov program
Generic intervention based on quit.gov sessions.
|
Behavioral: Quit.gov program
7-10 minute generic videos directing participants through quit.gov program |
Experimental: TinCat
Individualized asynchronous telehealth including LGBTQ+ affirming components.
|
Behavioral: TinCat
7-10 minute personalized video sessions based in tobacco cessation modules. |
- Tobacco use [ Time Frame: 11 weeks ]
Cigarette and vape assessments based on prior research on vaping/smoking:
Cigarette: Today, did you have at least one puff on a cigarette (yes/no) IF YES, THEN How many cigarettes did you smoked (at least one puff) (1-"more than 60").
Vaping: Today, did you use an electronic nicotine delivery system (i.e., a vape containing nicotine), even just one puff? (yes/no) IF YES, THEN How many times they had at least one puff (1 time, 2-5 times, 6-10 times, 11-15 times, 16-20 times, 21-25 times, 26-30 times, 31 or more times).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age 18 and over
- Live in Greater Austin
- Identify as LGBTQ+
- Current smokers
- High speed internet access
Exclusion Criteria:
- Exceed screener cutoff for suicide risk
- Exceed screener cutoff for borderline personality disorder
- Report current active substance use other than tobacco that interferes with functioning
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05499364
Contact: Mike Parent, PhD | 352-642-2404 | michael.parent@austin.utexas.edu |
Responsible Party: | Michael Parent, Associate professor, University of Texas at Austin |
ClinicalTrials.gov Identifier: | NCT05499364 |
Other Study ID Numbers: |
STUDY00003092 |
First Posted: | August 12, 2022 Key Record Dates |
Last Update Posted: | August 16, 2022 |
Last Verified: | August 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Tobacco Use Disorder Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |